NVRO Nevro Corp

  1. Stocks
  2. Healthcare
  3. NYSE: NVRO

Price (delayed)

$9.74

Market cap

$357.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.28

Enterprise value

$484.73M

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. ...

Highlights
NVRO's quick ratio is up by 11% since the previous quarter
The EPS has increased by 11% since the previous quarter
The debt is up by 11% year-on-year
The equity has contracted by 8% YoY and by 5% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.nevro.com
Peers: ISRG TMO OFIX TNDM

Key stats

What are the main financial stats of NVRO
Market
Shares outstanding
36.73M
Market cap
$357.74M
Enterprise value
$484.73M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.27
Price to sales (P/S)
0.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.13
Earnings
Revenue
$430.75M
EBIT
-$75.27M
EBITDA
-$62.39M
Free cash flow
-$70.97M
Per share
EPS
-$2.28
Free cash flow per share
-$1.95
Book value per share
$7.65
Revenue per share
$11.81
TBVPS
$14.56
Balance sheet
Total assets
$596.05M
Total liabilities
$317.51M
Debt
$217.9M
Equity
$278.54M
Working capital
$425.83M
Liquidity
Debt to equity
0.78
Current ratio
7.38
Quick ratio
5.38
Net debt/EBITDA
-2.04
Margins
EBITDA margin
-14.5%
Gross margin
68.9%
Net margin
-19.2%
Operating margin
-22.1%
Efficiency
Return on assets
-14%
Return on equity
-28.7%
Return on invested capital
-12.4%
Return on capital employed
-14.2%
Return on sales
-17.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NVRO stock price

How has the Nevro stock price performed over time
Intraday
-1.42%
1 week
7.03%
1 month
14.19%
1 year
-60.96%
YTD
-54.74%
QTD
15.68%

Financial performance

How have Nevro's revenue and profit performed over time
Revenue
$430.75M
Gross profit
$296.96M
Operating income
-$95.35M
Net income
-$82.59M
Gross margin
68.9%
Net margin
-19.2%
The net margin is up by 12% since the previous quarter
The net income has grown by 10% from the previous quarter
The operating margin has grown by 6% from the previous quarter
The gross profit has grown by 5% YoY and by 2.4% from the previous quarter

Growth

What is Nevro's growth rate over time

Valuation

What is Nevro stock price valuation
P/E
N/A
P/B
1.27
P/S
0.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.13
The EPS has increased by 11% since the previous quarter
NVRO's P/B is 86% below its 5-year quarterly average of 9.3 and 48% below its last 4 quarters average of 2.5
The equity has contracted by 8% YoY and by 5% from the previous quarter
The P/S is 88% lower than the 5-year quarterly average of 7.3 and 51% lower than the last 4 quarters average of 1.7
The revenue has grown by 3.8% YoY

Efficiency

How efficient is Nevro business performance
The return on sales has increased by 17% since the previous quarter
The company's return on invested capital rose by 15% QoQ
The ROA has grown by 11% from the previous quarter
NVRO's return on equity is up by 9% since the previous quarter

Dividends

What is NVRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVRO.

Financial health

How did Nevro financials performed over time
NVRO's total assets is 88% greater than its total liabilities
The total liabilities has grown by 16% YoY but it has contracted by 7% from the previous quarter
Nevro's current ratio has increased by 16% QoQ and by 3.2% YoY
The debt is 22% smaller than the equity
The debt to equity has increased by 20% YoY and by 5% QoQ
The debt is up by 11% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.